Methods for treating drug-resistant hepatitis C virus infection with a 5,5-fused arylene or heteroarylene hepatitis C virus inhibitor

• 收藏
• 分享

专利权人:

Idenix Pharmaceuticals; Inc.

发明人:

Dousson, Cyril B.,Dukhan, David,Parsy, Christopher Claude,Pierra, Claire,Alexandre, Francois-Rene,Brandt, Guillaume,Da Costa, Daniel,Rahali, Houcine,Paparin, Jean-laurent,Derock, Michel,Convard, Thie

申请号：

AU2012236377

公开号：

AU2012236377A1

申请日:

2012.03.30

申请国别(地区):

AU

年份:

2013

代理人:

摘要：

Provided herein are methods for treating or preventing drug-resistant hepatitis C virus infection in a subject, which comprises administering to the subject a 5,5-fused heteroarylene hepatitis C virus inhibitor compound, for example, of Formula I, IA, or IB.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/